Review
doi: 10.1038/nrg909.
Genes and patent policy: rethinking intellectual property rights
Affiliations
- PMID: 12360238
- DOI: 10.1038/nrg909
Item in Clipboard
Review
Genes and patent policy: rethinking intellectual property rights
Nat Rev Genet.
2002 Oct.
Abstract
Concerns about human gene patents go beyond moral disquiet about creating a commodity from a part of the human body and also beyond legal questions about whether genes are unpatentable products of nature. New concerns are being raised about harm to public health and to research. In response to these concerns, various policy options, such as litigation, legislation, patent pools and compulsory licensing, are being explored to ensure that gene patents do not impede the practice of medicine and scientific progress.
Comment in
-
Genetics and market forces.Nat Rev Genet. 2002 Oct;3(10):734. doi: 10.1038/nrg918. Nat Rev Genet. 2002. PMID: 12360229 No abstract available.
Similar articles
-
Intellectual property and biotechnology: the U.S. internal experience--Part II.Kennedy Inst Ethics J. 2006 Jun;16(2):105-28. doi: 10.1353/ken.2006.0007. Kennedy Inst Ethics J. 2006. PMID: 17036443
-
Ethico-legal issues in biomedicine patenting: a patent professional viewpoint.Sci Eng Ethics. 2005 Jan;11(1):117-36. doi: 10.1007/s11948-005-0064-6. Sci Eng Ethics. 2005. PMID: 15727007
-
Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.Am J Bioeth. 2002 Summer;2(3):29-39. doi: 10.1162/152651602760250084. Am J Bioeth. 2002. PMID: 12230852 No abstract available.
-
Patent prosecution strategies for biotechnological inventions.Assay Drug Dev Technol. 2004 Dec;2(6):697-702. doi: 10.1089/adt.2004.2.697. Assay Drug Dev Technol. 2004. PMID: 15674028 Review.
-
Bio-patents, law and ethics. Critical analysis of the EU biotechnology directive.Rev Derecho Genoma Hum. 2003 Jul-Dec;(19):187-203. Rev Derecho Genoma Hum. 2003. PMID: 15032104 Review. No abstract available.
Cited by
-
Myriad Genetics: In the eye of the policy storm.Genet Med. 2010 Apr;12(4 Suppl):S39-70. doi: 10.1097/GIM.0b013e3181d72661. Genet Med. 2010. PMID: 20393310 Free PMC article.
-
Changing the rules of the game: addressing the conflict between free access to scientific discovery and intellectual property rights.Nat Biotechnol. 2010 Feb;28(2):137-40. doi: 10.1038/nbt0210-137. Nat Biotechnol. 2010. PMID: 20139948 No abstract available.
-
Genetics and public health--evolution, or revolution?J Epidemiol Community Health. 2004 Nov;58(11):894-9. doi: 10.1136/jech.2003.018515. J Epidemiol Community Health. 2004. PMID: 15483303 Free PMC article. Review.
-
It's about scientific secrecy, dummy: a better equilibrium among genomics patenting, scientific research and health care.Sci Eng Ethics. 2012 Jun;18(2):263-84. doi: 10.1007/s11948-011-9257-3. Epub 2011 Feb 13. Sci Eng Ethics. 2012. PMID: 21318322
-
The importance of being inventive. Critics claim that patents on genes may lead to very broad monopolies and inhibit further innovation. The European patent system provides efficient legal means to address these issues.EMBO Rep. 2004 Feb;5(2):119-23. doi: 10.1038/sj.embor.7400068. EMBO Rep. 2004. PMID: 14755300 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
